XML 53 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
ACQUISITIONS, DIVESTITURES AND LICENSING ARRANGEMENTS (Acquisitions and Divestitures) (Details)
$ in Millions
9 Months Ended
Sep. 30, 2017
USD ($)
SK Biotek [Member]  
Divestitures  
Expected proceeds from divestiture of a business $ 140
Assets held-for-sale 140
Asset impairment charges 128
IFM [Member]  
Asset Acquisition [Line Items]  
Asset acquisition payment 300
Contingent development and regulatory milestone payments for first product from the two programs 1,000
Contingent development and regulatory milestone payments for subsequent products 555
Upfront payment for future negotiation rights 25
Upfront payment allocated to research and development expenses 310
Upfront payment allocated to deferred tax asset 15
Flexus [Member]  
Asset Acquisition [Line Items]  
Asset acquisition milestone payment 100
Cardioxyl [Member]  
Asset Acquisition [Line Items]  
Asset acquisition milestone payment $ 100